|
In € millions, except earnings per share and dividend (in €) |
2019 |
2020 |
2021 (3) |
2022(3) |
2023(3) |
|
Order intake |
19,142 |
18,476 |
19,909 |
23,551 |
23,132 |
|
Order book at end of period |
33,839 |
34,430 |
34,744 |
40,957 |
45,251 |
|
Sales |
18,401 |
16,989 |
16,192 |
17,569 |
18,428 |
|
Total change |
+16.1% |
-7.7% |
+5.3% |
+8.5% |
+4.9% |
|
Organic change |
+0.8% |
-10.4% |
+5.3% |
+5.5% |
+7.9% |
|
EBIT (1) |
2,008 |
1,352 |
1,649 |
1,935 |
2,132 |
|
In % of sales |
10.9% |
8.0% |
10.2% |
11.0% |
11.6% |
|
Adjusted net income , Group share (1) |
1,405 |
937 |
1,361 |
1,556 |
1,768 |
|
Consolidated net income, Group share |
1,122 |
483 |
1,089 |
1,121 |
1,023 |
|
Adjusted net income Group share, per share (EPS)(1) |
6.61 |
4.40 |
6.39 |
7.35 |
8.48 |
|
Dividend per share |
0.60 (2) |
1.76 |
2.56 |
2.94 |
3.40(4) |
|
Free operating cash-flow (1) |
1,372 |
1,057 |
2,515 |
2,527 |
2,026 |
|
Net cash position (debt) at end of period |
-3,311 |
-2,549 |
-795 |
-35 |
-4,000 |
|
Self-funded R&D |
1,097 |
1,025 |
1,027 |
1,064 |
1,108 |
|
Consolidated headcount at year-end |
82,605 |
80,702 |
81,098 |
76,776 (5) |
80,901(5) |
- (1) Non-GAAP measures. See definitions in the corresponding reference documents.
- (2) Amount adjusted down in the context of the Covid-19 crisis. Initial amount: €2.65
- (3) 2021, 2022 and 2023 figures have been adjusted to reflect the application of IFRS5 (Transport disposal)
- (4) The Board of Directors decided to propose to the shareholders, who will convene at the Annual General Meeting on May 15, 2024, payment of a dividend of €3.40 per share.
- (5) Excluding Transport business.